Vanda Pharmaceuticals Aktie
3,70
EUR
±0,00
EUR
±0,00
%
4,48
USD
+0,07
USD
+1,59
%
Werbung
Vanda Pharmaceuticals Aktie Analyse
| 04.12.18 | Vanda Pharmaceuticals Overweight | Cantor Fitzgerald | |
| 21.09.18 | Vanda Pharmaceuticals Outperform | Oppenheimer & Co. Inc. | |
| 19.01.18 | Vanda Pharmaceuticals Buy | Seaport Global Securities | |
| 26.05.17 | Vanda Pharmaceuticals Buy | H.C. Wainwright & Co. | |
| 09.11.16 | Vanda Pharmaceuticals Buy | Aegis Capital | |
| 09.01.15 | Vanda Pharmaceuticals Buy | Canaccord Adams | |
| 09.12.09 | Vanda Pharmaceuticals buy | Jefferies & Company Inc. | |
| 17.06.08 | Vanda Pharmaceuticals | Hot Stocks Investor | |
|
Werbung
|
|||
| 12.11.07 | Vanda Pharmaceuticals outperform | Friedman, Billings Ramsey & Co | |
| 01.10.07 | Vanda Pharmaceuticals outperform | Friedman, Billings Ramsey & Co | |
| 15.06.07 | Vanda Pharmaceuticals outperform | Friedman, Billings Ramsey & Co | |
Werbung
Werbung